Federal Register / Vol. 87, No. 111 / Thursday, June 9, 2022 / Notices 35215 

SUMMARY: The Agency for Healthcare 

Research and Quality (AHRQ) 

announces a Special Emphasis Panel 

(SEP) meeting on ‘‘Diagnostic Centers of 

Excellence: Partnerships to Improve 

Diagnostic Safety and Quality (R18).’’ 

This SEP meeting will be closed to the 

public. 

DATES: July 14–15, 2022 

ADDRESSES: Agency for Healthcare 

Research and Quality, (Video Assisted 

Review), 5600 Fishers Lane, Rockville, 

Maryland 20857. 

FOR FURTHER INFORMATION CONTACT: 

Jenny Griffith, Committee Management 

Officer, Office of Extramural Research, 

Education and Priority Populations, 

Agency for Healthcare Research and 

Quality, (AHRQ), 5600 Fishers Lane, 

Rockville, Maryland 20857. Telephone: 

(301) 427–1557. 

SUPPLEMENTARY INFORMATION: A Special 

Emphasis Panel is a group of experts in 

fields related to health care research 

who are invited by AHRQ, and agree to 

be available, to conduct on an as needed 

basis, scientific reviews of applications 

for AHRQ support. Individual members 

of the Panel do not attend regularly 

scheduled meetings and do not serve for 

fixed terms or a long period of time. 

Rather, they are asked to participate in 

particular review meetings which 

require their type of expertise. 

The SEP meeting referenced above 

will be closed to the public in 

accordance with the provisions set forth 

in 5 U.S.C. app. 2, section 10(d), 5 

U.S.C. 552b(c)(4), and 5 U.S.C. 

552b(c)(6). Grant applications for 

‘‘Diagnostic Centers of Excellence: 

Partnerships to Improve Diagnostic 

Safety and Quality (R18)’’ are to be 

reviewed and discussed at this meeting. 

The grant applications and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Agenda items for this meeting are 

subject to change as priorities dictate. 

Dated: June 6, 2022. 

Marquita Cullom, 

Associate Director. 

[FR Doc. 2022–12433 Filed 6–8–22; 8:45 am] 

BILLING CODE 4160–90–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket No. CDC–2022–0079] 

Advisory Committee on Immunization 

Practices (ACIP) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting and request 

for comment. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

Centers for Disease Control and 

Prevention (CDC), located within the 

Department of Health and Human 

Services (HHS), announces the 

following meeting of the Advisory 

Committee on Immunization Practices 

(ACIP). This meeting is open to the 

public. Time will be available for public 

comment. 

DATES: The meeting will be held on June 

17, 2022, from 10:00 a.m. to 3:30 p.m., 

EDT, and June 18, 2022, from 10:00 a.m. 

to 4:00 p.m., EDT (times subject to 

change). The meeting will be webcast 

live via the World Wide Web. Written 

comments must be received on or before 

June 21, 2022. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2022– 

0079, by either of the following 

methods: 

• Federal eRulemaking Portal: 

https://www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Centers for Disease Control 

and Prevention, 1600 Clifton Road NE, 

Mailstop H24–8, Atlanta, Georgia 

30329–4027, Attn: June 17–18, 2022, 

ACIP Meeting. 

Instructions: All submissions received 

must include the Agency name and 

Docket Number. All relevant comments 

received in conformance with the 

https://www.regulations.gov suitability 

policy will be posted without change to 

https://www.regulations.gov, including 

any personal information provided. For 

access to the docket to read background 

documents or comments received, go to 

https://www.regulations.gov. 

FOR FURTHER INFORMATION CONTACT: 

Stephanie Thomas, ACIP Committee 

Management Specialist, Centers for 

Disease Control and Prevention, 

National Center for Immunization and 

Respiratory Diseases, 1600 Clifton Road 

NE, Mailstop H24–8, Atlanta, Georgia 

30329–4027; Telephone: (404) 639– 

8367; Email: ACIP@cdc.gov. 

SUPPLEMENTARY INFORMATION: In 

accordance with 41 CFR 102–3.150(b), 

less than 15 calendar days’ notice is 

being given for this meeting due to the 

exceptional circumstances of the 

COVID–19 pandemic and rapidly 

evolving COVID–19 vaccine 

development and regulatory processes. 

The Secretary of Health and Human 

Services has determined that COVID–19 

is a Public Health Emergency. A notice 

of this ACIP meeting has also been 

posted on CDC’s ACIP website at: 

https://www.cdc.gov/vaccines/acip/ 

index.html. In addition, CDC has sent 

notice of this ACIP meeting by email to 

those who subscribe to receive email 

updates about ACIP. 

Purpose: The committee is charged 

with advising the Director, CDC, on the 

use of immunizing agents. In addition, 

under 42 U.S.C. 1396s, the committee is 

mandated to establish and periodically 

review and, as appropriate, revise the 

list of vaccines for administration to 

vaccine-eligible children through the 

Vaccines for Children program, along 

with schedules regarding dosing 

interval, dosage, and contraindications 

to administration of vaccines. Further, 

under provisions of the Affordable Care 

Act, section 2713 of the Public Health 

Service Act, immunization 

recommendations of the ACIP that have 

been approved by the CDC Director and 

appear on CDC immunization schedules 

must be covered by applicable health 

plans. 

Matters to be Considered: The agenda 

will include discussions on the use of 

COVID–19 pediatric vaccines. A 

recommendation vote(s) is scheduled. 

Agenda items are subject to change as 

priorities dictate. For more information 

on the meeting agenda, visit https://

www.cdc.gov/vaccines/acip/meetings/ 

index.html. The meeting will be webcast 

live via the World Wide Web; for more 

information on ACIP, visit the ACIP 

website: https://www.cdc.gov/vaccines/ 

acip/index.html. 

Public Participation 

Interested persons or organizations 

are invited to participate by submitting 

written views, recommendations, and 

data. Please note that comments 

received, including attachments and 

other supporting materials, are part of 

the public record and are subject to 

public disclosure. Comments will be 

posted on https://www.regulations.gov. 

Therefore, do not include any 

information in your comment or 

supporting materials that you consider 

confidential or inappropriate for public 

disclosure. If you include your name, 

contact information, or other 

information that identifies you in the 

body of your comments, that 

information will be on public display. 


lotter on DSK11XQN23PROD with NOTICES1
35216 Federal Register / Vol. 87, No. 111 / Thursday, June 9, 2022 / Notices 

CDC will review all submissions and 

may choose to redact, or withhold, 

submissions containing private or 

proprietary information such as Social 

Security numbers, medical information, 

inappropriate language, or duplicate or 

near duplicate examples of a mass-mail 

campaign. CDC will carefully consider 

all comments submitted into the docket. 

Written Public Comment: The docket 

will be opened to receive written 

comments on June 9, 2022. Written 

comments must be received on or before 

June 21, 2022. 

Oral Public Comment: This meeting 

will include time for members of the 

public to make an oral comment. Oral 

public comment will occur before any 

scheduled votes, including all votes 

relevant to the ACIP’s Affordable Care 

Act and Vaccines for Children program 

roles. Priority will be given to 

individuals who submit a request to 

make an oral public comment before the 

meeting according to the procedures 

below. 

Procedure for Oral Public Comment: 

All persons interested in making an oral 

public comment at the June 17–18, 

2022, ACIP meeting must submit a 

request at https://www.cdc.gov/ 

vaccines/acip/meetings/index.html no 

later than 11:59 p.m., EDT, June 15, 

2022, according to the instructions 

provided. 

If the number of persons requesting to 

speak is greater than can be reasonably 

accommodated during the scheduled 

time, CDC will conduct a lottery to 

determine the speakers for the 

scheduled public comment session. 

CDC staff will notify individuals 

regarding their request to speak by email 

on June 16, 2022. To accommodate the 

significant interest in participation in 

the oral public comment session of 

ACIP meetings, each speaker will be 

limited to three minutes, and each 

speaker may speak only once per 

meeting. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–12577 Filed 6–7–22; 4:15 pm] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifiers: CMS–10387, CMS– 

10573 and CMS–10106] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 

(PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, and to allow 

a second opportunity for public 

comment on the notice. Interested 

persons are invited to send comments 

regarding the burden estimate or any 

other aspect of this collection of 

information, including the necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions, the accuracy of 

the estimated burden, ways to enhance 

the quality, utility, and clarity of the 

information to be collected, and the use 

of automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

DATES: Comments on the collection(s) of 

information must be received by the 

OMB desk officer by July 11, 2022. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, you may make your request 

using one of following: 

1. Access CMS’ website address at 

website address at: https://

www.cms.gov/Regulations-andGuidance/Legislation/Paperwork

ReductionActof1995/PRA-Listing. 

FOR FURTHER INFORMATION CONTACT: 

William Parham at (410) 786–4669. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. The term ‘‘collection of 

information’’ is defined in 44 U.S.C. 

3502(3) and 5 CFR 1320.3(c) and 

includes agency requests or 

requirements that members of the public 

submit reports, keep records, or provide 

information to a third party. Section 

3506(c)(2)(A) of the PRA (44 U.S.C. 

3506(c)(2)(A)) requires federal agencies 

to publish a 30-day notice in the 

Federal Register concerning each 

proposed collection of information, 

including each proposed extension or 

reinstatement of an existing collection 

of information, before submitting the 

collection to OMB for approval. To 

comply with this requirement, CMS is 

publishing this notice that summarizes 

the following proposed collection(s) of 

information for public comment: 

1. Type of Information Collection 

Request: Revision of a currently 

approved collection; Title of 

Information Collection: Minimum Data 

Set 3.0 Nursing Home and Swing Bed 

Prospective Payment System (PPS) For 

the collection of data related to the 

Patient Driven Payment Model and the 

Skilled Nursing Facility Quality 

Reporting Program (QRP); Use: We are 

requesting to implement the MDS 3.0 

v1.17.2 from Oct 1, 2020 to Oct 1, 2023. 

On May 15, 2020, in response to State 

Medicaid Agency and stakeholder 

requests, we updated the MDS 3.0 item 

sets to version 1.17.2. The changes in 

this version will allow State Medicaid 

Agencies to collect Patient Driven 

Payment Model (PDPM) payment codes 

and thereby inform their future payment 

models. Calculation of the PDPM 

payment code on OBRA assessment is 

not a federal requirement. These item 

set changes do not reflect any change in 

burden from the previous version, MDS 

3.0 v1.17.1. 

CMS uses the MDS 3.0 PPS Item Set 

to collect the data used to reimburse 

skilled nursing facilities for SNF-level 

care furnished to Medicare beneficiaries 

and to collect information for quality 

measures and standardized patient 

assessment data under the SNF QRP. 

Form Number: CMS–10387 (OMB 

control number: 0938–1140); Frequency: 

Yearly; Affected Public: Private Sector: 

Business or other for-profit and not-forprofit institutions; Number of 

Respondents: 15,471; Total Annual 

Responses: 4,905,042; Total Annual 


lotter on DSK11XQN23PROD with NOTICES1